psilocybin + modafinil

Psilocybin + modafinil is a non-standard, unapproved combination of two pharmacologically distinct agents. Psilocybin is a naturally occurring psychedelic compound that acts primarily as a serotonin 2A receptor agonist, leading to altered perception, cognition, and mood. It is being investigated for its potential in treating depression and other psychiatric disorders[1]. Modafinil is a synthetic wakefulness-promoting agent approved for narcolepsy and other sleep disorders; it acts mainly by increasing catecholamine (dopamine, norepinephrine) levels through inhibition of dopamine reuptake transporters and activation of orexin neurons[6][3]. There are no known approved pharmaceutical products or clinical trials specifically combining these two agents. The combination would theoretically merge the psychedelic effects of psilocybin with the cognitive-enhancing and stimulant properties of modafinil. No established safety or efficacy data exist for this combination.